Latest Breaking News On - Cytokinetics incorporated - Page 1 : comparemela.com

Platinum Investment Management Ltd Takes $1 60 Million Position in Cytokinetics, Incorporated (NASDAQ:CYTK)

Platinum Investment Management Ltd. purchased a new stake in Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) in the 4th quarter, HoldingsChannel.com reports. The institutional investor purchased 19,138 shares of the biopharmaceutical company’s stock, valued at approximately $1,598,000. Several other hedge funds have also made changes to their positions in the company. Seven Eight Capital LP purchased […]

United statesRobert arthur harringtonFady ibraham malikRaymond jamesRafferty asset managementCytokinetics company profilePlatinum investment management ltdCytokinetics incorporatedAsset management incPlatinum investment managementFree reportEight capitalPoint capitalHill management partnersAsset managementManagement inc

Sectoral Asset Management Inc Has $586,000 Stake in Cytokinetics, Incorporated (NASDAQ:CYTK)

Sectoral Asset Management Inc. reduced its position in shares of Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) by 94.1% during the 4th quarter, HoldingsChannel.com reports. The fund owned 7,013 shares of the biopharmaceutical company’s stock after selling 111,290 shares during the quarter. Sectoral Asset Management Inc.’s holdings in Cytokinetics were worth $586,000 as of its most […]

United statesFady ibraham malikRobert arthur harringtonRaymond jamesSecurities exchange commissionSectoral asset management incExchange commissionFinancial services group incQuadrant capital groupCytokinetics incorporatedMutual of america capital managementSectoral asset managementFree reportAsset managementState retirementPension system

Cytokinetics, Incorporated (NASDAQ:CYTK) Director Robert Arthur Harrington Sells 1,580 Shares

Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) Director Robert Arthur Harrington sold 1,580 shares of the company’s stock in a transaction on Monday, June 3rd. The shares were sold at an average price of $48.64, for a total transaction of $76,851.20. Following the sale, the director now directly owns 15,541 shares in the company, valued […]

United statesRobert arthur harringtonRaymond jamesCetera advisorsMurchinson ltdCytokinetics company profileSecurities exchange commissionCastleark managementComerica bankCytokinetics incorporatedGet free reportDirector robert arthur harringtonExchange commissionCytokinetics daily

Cytokinetics, Incorporated (NASDAQ:CYTK) Director Sells $76,851 20 in Stock

Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) Director Robert Arthur Harrington sold 1,580 shares of the company’s stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $48.64, for a total value of $76,851.20. Following the transaction, the director now directly owns 15,541 shares in the company, valued […]

Raymond jamesRobert arthur harringtonCetera advisorsMurchinson ltdSecurities exchange commissionCastleark managementComerica bankCytokinetics incorporatedGet free reportDirector robert arthur harringtonExchange commissionCytokinetics daily

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Cytokinetics incorporated